On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research projects aimed at advancing stem cell and gene therapy treatments for a variety conditions ranging from neurodegenerative diseases and blood cancers to HIV/AIDS.

The awards supported six projects in the Agencyﾒs clinical program which provides funding for eligible stem cell and gene therapy-based projects through any stage of clinical trial activity.